SENSEI BIOTHERAPEUTICS INC (SNSE) Stock Price, Quote, News and Overview
NASDAQ:SNSE - Nasdaq - US81728A1088 - Common Stock - Currency: USD
SNSE Quote, Performance and Key Statistics
SENSEI BIOTHERAPEUTICS INC
NASDAQ:SNSE (2/10/2025, 10:18:25 PM)
Premarket: 0.48 0 (0%)0.48
-0.01 (-1.76%)
The current stock price of SNSE is 0.48 USD. In the past month the price decreased by -6.34%. In the past year, price decreased by -36.84%.
SNSE Latest News and Analysis
Sensei Biotherapeutics to Participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery...
Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones
- Solnerstotug (SNS-101) dose expansion arm anticipated to be fully enrolled by end of Q1 2025 - - Clinical data update expected in Q2 2025 - BOSTON,...
Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference
BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery...
Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
- SNS-101 Phase 1/2 dose expansion clinical data expected in the first half of 2025 - - Organizational restructuring to focus resources on...
Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences
BOSTON, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage company focused on the discovery and development...
SNSE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.81 | 336.36B | ||
| AMGN | AMGEN INC | 14.87 | 158.46B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1620.59 | 121.03B | ||
| GILD | GILEAD SCIENCES INC | 21.55 | 118.99B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.13 | 75.86B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.66B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.35B | ||
| BNTX | BIONTECH SE-ADR | N/A | 27.63B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.41B | ||
| NTRA | NATERA INC | N/A | 22.73B | ||
| BIIB | BIOGEN INC | 8.73 | 20.77B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.18 | 15.43B |
Related stock screener links
About SNSE
Company Profile
Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company is headquartered in Rockville, Maryland and currently employs 27 full-time employees. The company went IPO on 2021-02-04. Through its Tumor Microenvironment Activated biologics (TMAb) platform, the Company develops conditionally active therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment to unleash T cells against tumors. Its lead investigational candidate is SNS-101, a conditionally active antibody designed to block the V-domain Ig suppressor of T cell activation checkpoint selectively within the low pH tumor microenvironment. The company is also developing SNS-102, a conditionally active monoclonal antibody targeting V-Set and Immunoglobulin Domain Containing 4 (VSIG-4); SNS-103, a conditionally active monoclonal antibody targeting ecto-nucleoside triphosphate diphosphohydrolase-1 (ENTPDase1), CD39; and SNS-201, a conditionally active VISTAxCD28 bispecific antibody.
Company Info
SENSEI BIOTHERAPEUTICS INC
1405 Research Blvd, Suite 125
Rockville MARYLAND 20850 US
CEO: John Celebi
Employees: 28
Company Website: https://www.senseibio.com/
Investor Relations: http://investors.senseibio.com/
Phone: 12402438000
SNSE FAQ
What is the stock price of SNSE?
The current stock price of SNSE is 0.48 USD.
What is the symbol for SENSEI BIOTHERAPEUTICS INC stock?
The exchange symbol of SENSEI BIOTHERAPEUTICS INC is SNSE and it is listed on the Nasdaq exchange.
On which exchange is SNSE stock listed?
SNSE stock is listed on the Nasdaq exchange.
Is SNSE a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for SNSE, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of SNSE.
Does SNSE stock pay dividends?
SNSE does not pay a dividend.
When does SNSE stock report earnings?
SNSE will report earnings on 2025-03-06, after the market close.
What is the Price/Earnings (PE) ratio of SNSE?
SNSE does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.19).
What is the Short Interest ratio of SNSE stock?
The outstanding short interest for SNSE is 4.58% of its float.
SNSE Technical Analysis
SNSE Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to SNSE. SNSE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
SNSE Financial Highlights
Over the last trailing twelve months SNSE reported a non-GAAP Earnings per Share(EPS) of -1.19. The EPS decreased by 9.85% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -55.96% | ||
| ROE | -65.1% | ||
| Debt/Equity | 0 |
SNSE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 89% to SNSE. The Buy consensus is the average rating of analysts ratings from 11 analysts.